Intuitive Surgical (ISRG)Director sold ~$55K
Amy L Ladd, Director at Intuitive Surgical, sold ~$55K of Intuitive Surgical shares.
- ~$55K
- Approx. value · 119 sh @ $463.50
- 120
- Holds after · shares reported
- Traded
- Apr 29, 2026
- Filed
- Apr 29, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 27, 2026Insider · 2 peopleInsiders: 2 sales (~$1.3M)
- Mar 2, 2026InsiderOfficer sold ~$62K of ISRG shares in the open market
- Mar 3, 2026Insider · 3 peopleInsiders: 3 sales (~$2.7M)
- Mar 4, 2026InsiderOfficer sold ~$1.18M of ISRG shares in the open market
- Mar 5, 2026InsiderOfficer sold ~$321K of ISRG shares in the open market
- Mar 6, 2026InsiderOfficer sold ~$318K of ISRG shares in the open market
- Mar 9, 2026InsiderOfficer sold ~$313K of ISRG shares in the open market
- Mar 10, 2026InsiderOfficer sold ~$52K of ISRG shares in the open market
- Mar 11, 2026FDAFDA device clearance: da Vinci Force Feedback Instruments
- Mar 11, 2026FDARecall: Intuitive 8 mm SureForm 30 Gray Reloads Reference Numbers: 48230M-05 and 48230M-06
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026CongressDisclosed purchase of ISRG — reported range $1,001 - $15,000
- Apr 2, 2026FDARecall: Brand Name: Da Vinci X and Da Vinci Xi Product Name: da Vinci X, Xi Surgical System Model/Catalog Number: IS4000; IS4200 Software Version: N/A Product Descript…
- Apr 21, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 22, 2026FDARecall: Da Vinci ASSY, PSS, SP1098, Part Number: 380601
- Apr 24, 2026FDARecall: Brand Name: Da Vinci 5 Product Name: ASSY,DV5 TOWER,IS5000 Model/Catalog Number: 380746 Software Version: N/A Product Description: Preface: This report under 2…
- Apr 28, 2026InsiderDirector sold ~$237K of ISRG shares in the open market
- Apr 29, 2026 · this disclosureInsiderDirector sold ~$55K of ISRG shares in the open market
What came next
- Apr 30, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote (and 1 more item)“Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan The Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan (the “Amended 2010 Plan”), which (i) increases the number of shares of common stock reserved…”
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 11, 2026InsiderOfficer sold ~$179K of ISRG shares in the open market
- May 18, 2026InsiderOfficer sold ~$7.6K of ISRG shares in the open market
- May 19, 2026InsiderOfficer sold ~$7.9K of ISRG shares in the open market
- May 20, 2026InsiderOfficer sold ~$7.9K of ISRG shares in the open market
- May 21, 2026InsiderOfficer sold ~$8K of ISRG shares in the open market
- May 22, 2026FDAFDA device clearance: da Vinci Firefly Imaging System
- May 22, 2026InsiderOfficer sold ~$7.9K of ISRG shares in the open market
- May 28, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company.”
- Jun 1, 2026InsiderOfficer sold ~$2.37M of ISRG shares in the open market
- Jun 8, 2026InsiderOfficer sold ~$9.7K of ISRG shares in the open market
- Jun 9, 2026InsiderOfficer sold ~$9.7K of ISRG shares in the open market
- Jun 10, 2026Insider · 2 peopleInsiders: 2 sales (~$179K)
- Jun 11, 2026InsiderOfficer sold ~$9.5K of ISRG shares in the open market
- Jun 12, 2026InsiderOfficer sold ~$10K of ISRG shares in the open market
- Jun 25, 2026Federal contract · $100K obligatedDepartment of Health and Human Services awarded Intuitive Surgical: $100K obligated to date
- Jul 14, 2026FDAFDA device clearance: Universal Seal (5-12 mm)
- Jul 16, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 23, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Intuitive Surgical
For Intuitive Surgical, OQRO holds 22 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 96 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ISRG page.
Other recent filings by Amy L Ladd, Director
- SEC Form 4 at Intuitive Surgical (ISRG)Aug 11, 2026
- SEC Form 4 at Intuitive Surgical (ISRG)Aug 11, 2026
- SEC Form 4 at Intuitive Surgical (ISRG)Apr 29, 2026
- SEC Form 4 at Intuitive Surgical (ISRG)Sep 4, 2025
- SEC Form 4 at Intuitive Surgical (ISRG)Sep 4, 2025
The full history of Amy L Ladd, Director is on the profile page.
How this filing works
Other disclosures at Intuitive Surgical
- SEC Form 4Sep 16, 2026
- SEC Form 4Sep 16, 2026
- SEC Form 144Sep 15, 2026
- SEC Form 4Sep 11, 2026
- SEC Form 4Sep 11, 2026
- SEC Form 4Sep 9, 2026
Everything OQRO holds on this company is on its ISRG page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
